Marie Dallibert

Why is it so complex to design an artificial heart ?

Why is it so complex to design an artificial heart ? Due to the limited availability of heart transplants, it is possible to use an artificial heart while waiting for a heart transplant.    After decades of research and development into total artificial hearts (TAH), there is only one solution that provides a transitional technological alternative while waiting for a heart transplant: there is no destination therapy yet that allows patients to live with a heart prosthesis in the long term.  ...
Read More

Numerical simulation of blood flow in the ventricle

Numerical simulation of blood flow in the ventricle The Procope Medicals cardiac prosthesis is monobloc, totally intracorporeal and orthotopic. It mimics the physiology of the heart. The two ventricles, driven by an electro-pneumatic mechanism, are synchronous like the natural heart. The two ventricles have their own hemodynamic regime, self-regulation and ensure an optimal response to the body’s needs. https://procope-medicals.com/wp-content/uploads/2023/02/Valve-mitrale-1.mp4 The hemodyn...
Read More

A sustainable alternative to the transplant shortage

A sustainable alternative to the heart transplant shortage Each year 200,000 heart failure patients worldwide are waiting for a heart transplant The number of patients on waiting lists and the shortage of organs are the main threats to organ transplantation: only 3% of patients receive a donor heart. In the case of end-stage heart failure, the last alternative is to replace the failing heart with a total artificial heart (TAH). The implantation is performed surgically in the same way as a heart...
Read More

Give more value to your investments

Give more value to your investments Innovation is a powerful driver of today’s economy and society. It brings new ideas, products and services that improve quality of life and stimulate economic growth. It is also a way to solve global challenges. In short, innovation is an invaluable asset that contributes to a more advanced and prosperous society. As investors, you can add value to these innovative companies. Becoming a shareholder of a company will allow you to obtain a tax reduction. D...
Read More

Xenotransplantation or artificial heart : What is the future of cardiac medicine ?

Xenotransplantation or artificial heart : What is the future of cardiac medicine ? In France, heart failure affects 1.5 million people per year, and 200,000 patients with acute heart failure are hospitalised each year, according to the official website of the French Health Insurance. Our country, like the rest of the world, has been confronted for years with a shortage of organs and tissues, while the need for transplants continues to increase (cf Agence de biomédecine). The extent of the short...
Read More

Press release of October,19th 2022

Procope Medicals validates the 1st phase of anatomical compatibility evaluation of its medical device Nantes, France, October 19, 2022 – Procope Medicals, developer of a fully implantable heart prosthesis, has completed the first phase of physical implants of its artificial heart device. The objective of the physical implantations is to validate the design (shape) and size (volume) of the cardiac prosthesis, which is available in 2 volumes, so that it can be suitable for the greatest nu...
Read More